All Biotech News

List of articles in category All Biotech News
Title	Published Date
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development	11/29/2023
Verici DX Plc Reaches a Global Licensing and Commercialisation Agreement with Thermo Fisher Scientific	11/15/2023
SciRhom Files Clinical Trial Application for First-in-Human Trials of Novel Antibody Against Autoimmune Diseases	11/15/2023
Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization	11/09/2023
Coriolis Pharma Re-Establishes Chair in Vaccine Development at Leiden University	11/06/2023
4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection	10/18/2023
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care	10/18/2023
BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI 2023 Conference	10/18/2023
Vetter Looks Ahead to Further Expansions to Meet Supply Chain Demand	10/17/2023
Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions	10/16/2023
Cerba Research Announces New Collective Focus on Transforming Research and Advancing Health	10/12/2023
The PolG Foundation Awards Over $3.5M in Academic Grants to Pioneer POLG Research	10/11/2023
Atriva Therapeutics Announces Publication of Proof of Concept (POC) / Phase 2a RESPIRE Study Data with Zapnometinib in Patients Hospitalized with COVID-19	10/04/2023
Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform	09/28/2023
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development	09/26/2023
Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab)	09/26/2023
MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications	09/25/2023
NecstGen and ProteoNic Report Development of Improved Viral Vectors through the Application of Premium 2G UNic™ Technology	09/19/2023
Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques	09/06/2023
MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzora® Cream in Greater China	08/31/2023
Vetter Earns Frost & Sullivan’s Customer Value Award for the Third Time	08/29/2023
T-CURX GmbH Announces Appointment of Two Industry Leaders to its Board of Directors	08/28/2023
Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis	08/25/2023
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification	08/17/2023
Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic	08/03/2023
Coriolis Pharma and RheaVita Join Forces in Collaboration for Continuous and Controlled Freeze-Drying Technology	07/31/2023
Polpharma Biologics Announces First-of-a-Kind Multiple Sclerosis Biosimilar Natalizumab Receives Positive CHMP Opinion	07/24/2023
Genomic Vision Launches HexaCard, a New Service to Characterize Cell Lines Used for Biomanufacturing and Cell & Gene Therapy	07/18/2023
Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research	06/27/2023
Genomic Vision Enters Distribution Agreement with CliniSciences	06/22/2023

Page 10 of 87